首页 正文

Current and Future Treatment Landscape of Transthyretin Amyloid Cardiomyopathy

{{output}}
Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive disease caused by the deposition of insoluble amyloid fibrils derived from misfolded transthyretin (TTR). The treatment landscape is rapidly evolving, with disease-modifying therapies now targetin... ...